By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Trevi Therapeutics 



New Haven  Connecticut    U.S.A.
Phone: 203-304-2499 Fax: 203-304-2434


SEARCH JOBS


Industry
Biotechnology






Company News
Trevi Therapeutics Announces Completion Of Enrollment In Phase II/III Study Of Nalbuphine ER In Prurigo Nodularis 6/2/2016 10:41:40 AM
Trevi Therapeutics To Present Two Posters At The National Kidney Foundation Spring 2016 Meeting 4/28/2016 11:27:37 AM
Trevi Therapeutics’ Data To Be Presented At The American Academy of Dermatology’s 74th Annual Meeting In Washington, DC 3/1/2016 12:57:15 PM
Trevi Therapeutics Selected To Present At The American Society Of Nephrology’s Kidney Week 2015 At High-Impact Clinical Trials Session With Phase II/III Data For Nalbuphine ER 10/29/2015 11:04:56 AM
Trevi Therapeutics Announces Positive Results From Phase II/III Trial In Uremic Pruritus 9/10/2015 10:02:10 AM
Trevi Therapeutics Announces Completion Of Enrollment In Pivotal Study Of Nalbuphine ER In Uremic Pruritus 3/31/2015 11:57:40 AM
Trevi Therapeutics Announces Initiation Of A Pivotal Study Of Nalbuphine ER In Prurigo Nodularis 3/11/2015 8:14:12 AM
Trevi Therapeutics To Present At The Annual Cowen and Company Healthcare Conference 2/23/2015 11:00:30 AM
Trevi Therapeutics Closes $15 Million Debt Facility Provided By Solar Capital And Square 1 Bank 1/8/2015 10:45:14 AM
Trevi Therapeutics To Present At The J.P. Morgan Healthcare Conference 1/5/2015 9:45:02 AM
123
//-->